Total Payments
$2,105
2024 Payments
$979.37
Companies
12
Transactions
51
Medicare Patients
375
Medicare Billing
$28,910
Payment Breakdown by Category
Food & Beverage$2,105 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,105 | 51 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $571.92 | 11 | $0 (2024) |
| Janssen Biotech, Inc. | $384.99 | 3 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $239.11 | 2 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $201.99 | 7 | $0 (2023) |
| Lilly USA, LLC | $163.44 | 9 | $0 (2022) |
| Biohaven Pharmaceutical Holding Company Ltd. | $131.59 | 10 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $127.54 | 1 | $0 (2024) |
| Gilead Sciences, Inc. | $125.00 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $67.44 | 3 | $0 (2021) |
| Amgen Inc. | $52.17 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $979.37 | 8 | Janssen Biotech, Inc. ($259.97) |
| 2023 | $384.62 | 7 | ABBVIE INC. ($142.64) |
| 2022 | $579.62 | 29 | ABBVIE INC. ($146.42) |
| 2021 | $161.35 | 7 | Biohaven Pharmaceuticals, Inc. ($67.44) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $135.00 | General |
| Category: Immunology | ||||||
| 11/21/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $124.97 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $126.92 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $126.55 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $112.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 03/14/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $100.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/25/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $127.54 | General |
| Category: Neuroscience | ||||||
| 11/29/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/13/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $8.35 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/05/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/04/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $125.02 | General |
| Category: Immunology | ||||||
| 04/28/2023 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $123.26 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/22/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.17 | General |
| Category: Gastroenterology | ||||||
| 01/04/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Gastroenterology | ||||||
| 12/10/2022 | Lilly USA, LLC | EMGALITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $25.48 | General |
| Category: Neuroscience | ||||||
| 12/06/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.60 | General |
| Category: PRIMARY CARE | ||||||
| 12/06/2022 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Diabetes | ||||||
| 11/23/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: Gastroenterology | ||||||
| 11/09/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $123.08 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $8.51 | General |
| Category: PRIMARY CARE | ||||||
| 11/02/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: PRIMARY CARE | ||||||
| 10/26/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Gastroenterology | ||||||
| 10/22/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $6.15 | General |
| Category: PRIMARY CARE | ||||||
| 10/21/2022 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 375 | 420 | $135,405 | $28,910 |
Total Patients
375
Total Services
420
Medicare Billing
$28,910
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 103 | 132 | $30,555 | $7,090 | 23.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 55 | 61 | $23,912 | $4,930 | 20.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 53 | 54 | $23,436 | $4,704 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 53 | $14,734 | $3,266 | 22.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 26 | 28 | $17,836 | $3,197 | 17.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 27 | 30 | $10,246 | $2,437 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 39 | 39 | $7,878 | $1,756 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 23 | 23 | $6,808 | $1,530 | 22.5% |
About Sinaro Men
Sinaro Men is a Surgical healthcare provider based in Fairhaven, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/01/2021. The National Provider Identifier (NPI) number assigned to this provider is 1962078857.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sinaro Men has received a total of $2,105 in payments from pharmaceutical and medical device companies, with $979.37 received in 2024. These payments were reported across 51 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($2,105).
As a Medicare-enrolled provider, Men has provided services to 375 Medicare beneficiaries, totaling 420 services with total Medicare billing of $28,910. Data is available for 1 year (2023–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgical
- Location Fairhaven, MA
- Active Since 06/01/2021
- Last Updated 06/06/2024
- Taxonomy Code 363AS0400X
- Entity Type Individual
- NPI Number 1962078857
Products in Payments
- TREMFYA (Drug) $259.97
- VOQUEZNA (Drug) $239.11
- NURTEC ODT (Drug) $199.03
- LINZESS (Drug) $162.45
- UBRELVY (Drug) $151.94
- ZEPOSIA (Drug) $127.54
- SKYRIZI (Biological) $126.92
- STELARA (Biological) $125.02
- Epclusa (Drug) $125.00
- CREON (Drug) $111.23
- TRULANCE (Drug) $102.82
- XIFAXAN (Drug) $99.17
- EMGALITY (Drug) $77.75
- Aimovig (Biological) $52.17
- TRULICITY (Drug) $49.10
- MOUNJARO (Drug) $36.59
- Talicia (Drug) $21.29
- VIBERZI (Drug) $19.38
- FASENRA (Biological) $18.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.